Skip to main content
. 2022 Nov 11;13:1058819. doi: 10.3389/fimmu.2022.1058819

Figure 3.

Figure 3

Landscapes of death causes in the pre-immunotherapy era (2000-2011, N=166,321) and in the immunotherapy era (2015-2017, N=40,172) for patients with metastatic non-small cell lung cancer. Number of deaths at each death cause was presented except lung cancer. Approximately 2% of them (N=4,215) had no definitive records of death causes.